Official Title
Expanded Access to Tavapadon
Brief Summary
This is an expanded access program (EAP) for eligible participants. This program isdesigned to provide access to tavapadon prior to approval by the local regulatory agency.Availability will depend on territory eligibility. A medical doctor must decide whetherthe potential benefit outweighs the risk of receiving an investigational therapy based onthe individual patient's medical history and program eligibility criteria.
Detailed Description
Not Provided
Available
Individual Patients
Parkinson Disease
Drug: Tavapadon
Oral: Tablet
Eligibility Criteria
Inclusion Criteria:
- The participant must not be eligible for a tavapadon clinical trial.
Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
United States
Locations
Endeavor Health /ID# 277884
Northbrook 4904056, Illinois 4896861, United States
Contacts
ABBVIE CALL CENTER
844-663-3742
abbvieclinicaltrials@abbvie.com
ABBVIE INC., Study Director
AbbVie
AbbVie
NCT Number
Keywords
Expanded Access
Pre-approval Access
Compassionate Use
Special Access Program
Named Patient Basis
Special Access Scheme
Parkinson Disease
Tavapadon
ABBV-1751
C25-978
MeSH Terms
Parkinson Disease